UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19

Current opinion in virology, 2021-10, Vol.50, p.17-22

2021

Volltextzugriff (PDF)

Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2

Trials, 2021-08, Vol.22 (1), p.561-561, Article 561

2021

Volltextzugriff (PDF)

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

The New England journal of medicine, 2019-12, Vol.381 (24), p.2293-2303

2019

Volltextzugriff (PDF)

Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2

Antimicrobial agents and chemotherapy, 2021-05, Vol.65 (5)

2021

Volltextzugriff (PDF)

The circadian clock rephases during lateral root organ initiation in Arabidopsis thaliana

Nature communications, 2015-07, Vol.6 (1), p.7641-7641, Article 7641

2015

Volltextzugriff (PDF)

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

Science translational medicine, 2022-01, Vol.14 (628), p.eabl7430

2022

Volltextzugriff (PDF)

Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events

The New England journal of medicine, 2010-04, Vol.362 (16), p.1463-1476

2010

Volltextzugriff (PDF)

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

The New England journal of medicine, 2010-04, Vol.362 (16), p.1477-1490

2010

Volltextzugriff (PDF)

Paraganglioma and other tumour detection rates in individuals with SDHx pathogenic variants by age of diagnosis and after the age of 50

Clinical endocrinology (Oxford), 2021-09, Vol.95 (3), p.447-452

2021

Volltextzugriff (PDF)

Midlife body mass index, central adiposity and neuropsychological performance over 10 years in women living with and without HIV

Frontiers in endocrinology (Lausanne), 2023-07, Vol.14, p.1108313

2023

Volltextzugriff (PDF)

Implementation and Impact of Patient Lay Navigator-led Advance Care Planning Conversations

Journal of pain and symptom management, 2017-04, Vol.53 (4), p.682-692

2017

Volltextzugriff (PDF)

Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e525-e528

2022

Volltextzugriff (PDF)

Novel Human Lipoxygenase Inhibitors Discovered Using Virtual Screening with Homology Models

Journal of medicinal chemistry, 2006-02, Vol.49 (4), p.1356-1363

2006

Volltextzugriff (PDF)

Evaluating temperature gradients across the posterior left atrium with radiofrequency ablation

Journal of cardiovascular electrophysiology, 2023-04, Vol.34 (4), p.880-887

2023

Volltextzugriff (PDF)

Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery

The New England journal of medicine, 2023-04, Vol.388 (15), p.1365-1375

2023

Volltextzugriff (PDF)

Recognition of the complexity facing residential care homes: a practitioner inquiry

Primary health care research & development, 2018-11, Vol.19 (6), p.584-590

2018

Volltextzugriff (PDF)

Population pharmacokinetics of molnupiravir in adults with COVID‐19: Lack of clinically important exposure variation across individuals

CPT: pharmacometrics and systems pharmacology, 2023-12, Vol.12 (12), p.1859-1871

2023

Volltextzugriff (PDF)

The effect of a brief action planning intervention on adherence to double-blind study medication, compared to a standard trial protocol, in the Atorvastatin in Factorial with Omega EE90 Risk Reduction in Diabetes (AFORRD) clinical trial: A cluster randomised sub-study

Diabetes research and clinical practice, 2016-10, Vol.120, p.56-64

2016

Volltextzugriff (PDF)

Validation of the e-NutLit, an Electronic Tool to Assess Nutrition Literacy

Journal of nutrition education and behavior, 2020-06, Vol.52 (6), p.607-614

2020

Volltextzugriff (PDF)

PO-682-08 THE POWER OF EP-BIOENGINEERING COLLABORATION: DEVELOPMENT OF A HEART-ESOPHAGEAL MODEL TO STUDY ENERGY TRANSFER BETWEEN TISSUES, EVALUATE RAPIDLY EVOLVING ABLATION STRATEGIES AND TOOLS FOR MITIGATION OF ESOPHAGEAL INJURY

Heart rhythm, 2022-05, Vol.19 (5), p.S368-S368

2022

Volltextzugriff (PDF)

CA-528-04 ANTERIOR WALL TEMPERATURE OF ESOPHAGUS DURING CATHETER ABLATION OF THE LA POSTERIOR WALL IS MARKEDLY HIGHER COMPARED TO LUMINAL TEMPERATURE

Heart rhythm, 2022-05, Vol.19 (5), p.S8-S9

2022

Volltextzugriff (PDF)

A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage

Nature cancer, 2021-06, Vol.2 (6), p.643-657

2021

Volltextzugriff (PDF)

Gene Expression Profiling Reveals Defined Functions of the ATP-Binding Cassette Transporter COMATOSE Late in Phase II of Germination

Plant physiology (Bethesda), 2007-04, Vol.143 (4), p.1669-1679

2007

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19

Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2

The circadian clock rephases during lateral root organ initiation in Arabidopsis thaliana

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events

A Genetics-First Approach to Dissecting the Heterogeneity of Autism: Phenotypic Comparison of Autism Risk Copy Number Variants

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

Paraganglioma and other tumour detection rates in individuals with SDHx pathogenic variants by age of diagnosis and after the age of 50

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

Midlife body mass index, central adiposity and neuropsychological performance over 10 years in women living with and without HIV

Implementation and Impact of Patient Lay Navigator-led Advance Care Planning Conversations

Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Novel Human Lipoxygenase Inhibitors Discovered Using Virtual Screening with Homology Models

Evaluating temperature gradients across the posterior left atrium with radiofrequency ablation

Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery

Recognition of the complexity facing residential care homes: a practitioner inquiry

Population pharmacokinetics of molnupiravir in adults with COVID‐19: Lack of clinically important exposure variation across individuals

The effect of a brief action planning intervention on adherence to double-blind study medication, compared to a standard trial protocol, in the Atorvastatin in Factorial with Omega EE90 Risk Reduction in Diabetes (AFORRD) clinical trial: A cluster randomised sub-study

Validation of the e-NutLit, an Electronic Tool to Assess Nutrition Literacy

PO-682-08 THE POWER OF EP-BIOENGINEERING COLLABORATION: DEVELOPMENT OF A HEART-ESOPHAGEAL MODEL TO STUDY ENERGY TRANSFER BETWEEN TISSUES, EVALUATE RAPIDLY EVOLVING ABLATION STRATEGIES AND TOOLS FOR MITIGATION OF ESOPHAGEAL INJURY

CA-528-04 ANTERIOR WALL TEMPERATURE OF ESOPHAGUS DURING CATHETER ABLATION OF THE LA POSTERIOR WALL IS MARKEDLY HIGHER COMPARED TO LUMINAL TEMPERATURE

A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage

Gene Expression Profiling Reveals Defined Functions of the ATP-Binding Cassette Transporter COMATOSE Late in Phase II of Germination

Suchergebnisse filtern